via Brigham and Women’s Hospital
Scientists at Brigham and Women’s Hospital (BWH) have developed a scalable, next-generation platelet bioreactor to generate fully functional human platelets in vitro. The work is a major biomedical advancement that will help address blood transfusion needs worldwide.
The study is published July 21, 2014 in Blood.
“The ability to generate an alternative source of functional human platelets with virtually no disease transmission represents a paradigm shift in how we collect platelets that may allow us meet the growing need for blood transfusions,” said Jonathan Thon, PhD, Division of Hematology, BWH Department of Medicine, lead study author.
According to the researchers, more than 2.17 million platelet units from donors are transfused yearly in the United States to treat patients undergoing chemotherapy, organ transplantation and surgery, as well as for those needing blood transfusions following a major trauma. However, increasing demand; a limited five-day shelf-life; and risk of contamination, rejection and infection have made blood platelet shortages common.
“Bioreactor-derived platelets theoretically have several advantages over conventional, donor-derived platelets in terms of safety and resource utilization,” said William Savage, MD, PhD, medical director, Kraft Family Blood Donor Center at Dana Farber Cancer Institute/Brigham and Women’s Hospital, who did not contribute to the study. “A major factor that has limited our ability to compare bioreactor platelets to donor platelets is the inefficiency of growing platelets, a problem that slows progress of clinical research. This study addresses that gap, while contributing to our understanding of platelet biology at the same time.”
Read more . . .
The Latest on: Platelet bioreactor
via Google News
The Latest on: Platelet bioreactor
- Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaqueson March 2, 2021 at 2:34 am
The COVID-19 pandemic is a global health crisis that poses a great challenge to the public health system of affected countries. Safe and effective vaccines are needed to overcome this crisis.
- Tissue Regeneration and Organ Repair: Science or Science Fiction?on March 1, 2021 at 4:01 pm
Dr. Marx described the optimization of culture conditions in a bioreactor system. Such system for the culture of lymphoid cells must ensure maximal sterility, and it should be made of highly ...
- Flow Cytometry News and Researchon February 24, 2021 at 4:00 pm
A new preprint research paper posted to the bioRxiv server provides a greater understanding of the aspect of humoral immunity against the virus – the plasma cells that pour out a flood of ...
- Sulfated polysaccharide directs therapeutic angiogenesis via endogenous VEGF secretion of macrophageson February 11, 2021 at 3:16 am
1 The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, P. R. China. 2 Key Laboratory for Ultrafine Materials of Ministry of Education, ...
- A single dose investigational subunit vaccine for human use against Nipah virus and Hendra viruson February 8, 2021 at 4:38 am
Total white blood cell counts, white blood cell differentials, red blood cell counts, platelet counts, hematocrit values, total hemoglobin, mean cell volume, mean corpuscular volume, and mean ...
- Bioreactor Generates Plateletson February 4, 2021 at 4:00 pm
Blood-platelet shortages may become a thing of the past, according to scientists at Brigham and Women's Hospital in Boston. The researchers have designed an industrial-strength bone marrow bioreactor ...
- A blueprint for translational regenerative medicineon February 2, 2021 at 4:00 pm
Normal wound healing is also regulated by coordinated cellular processes. The first responders to injury are platelets and neutrophils, which aggregate at the wound site and release growth factors and ...
- Transplantation of Engineered Heart Tissue as a Biological Cardiac Assist Device for Treatment of Dilated Cardiomyopathyon January 31, 2021 at 4:00 pm
The present idea is to pre-seed a decellularized artery with autologous endothelial progenitor cells for some days of culture in a rotating bioreactor. Thereafter, this pre-cultivated vessel ...
- Recombinant Protein Expression (Baculovirus System)on August 11, 2020 at 6:36 pm
Protein Production in Insect Cells: Protein production is performed on a small scale in conventional spinner culture vessels in the range of 150-1,000 ml volumes or on a large scale in oxygenated 5 ...
- The Intra-articular Injection of Stem Cells as Therapy for Articular Cartilage Repair - What is the Evidence?on March 18, 2018 at 5:07 am
The implantation of stem cells in combination with biodegradable scaffolds, differentiation factors, cytokines, growth factors, surface modifiers, peptides or genes (with or without the use of ...
via Bing News
